Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (51.78 KB, 5 trang )
Chapter 058. Anemia and
Polycythemia
(Part 12)
Approach to the Patient: Polycythemia
As shown in Fig. 58-18, the first step is to document the presence of an
increased red cell mass using the principle of isotope dilution by administering
51
Cr-labeled autologous red blood cells to the patient and sampling blood
radioactivity over a 2-h period.
If the red cell mass is normal (<36 mL/kg in men, <32 mL/kg in women),
the patient has spurious polycythemia. If the red cell mass is increased (>36 mL/kg
in men, >32 mL/kg in women), serum EPO levels should be measured.
If EPO levels are low or unmeasurable, the patient most likely has
polycythemia vera. Ancillary tests that support this diagnosis include elevated
white blood cell count, increased absolute basophil count, and thrombocytosis.
A mutation in JAK-2 (Val617Phe), a key member of the cytokine
intracellular signaling pathway, can be found in 70–95% of patients with
polycythemia vera.
Figure 58-18
An approach to diagnosing patients with polycythemia.
RBC, red blood cell; EPO, erythropoietin; COPD, chronic obstructive
pulmonary disease; AV, atrioventricular; IVP, intravenous pyelogram; hct,
hematocrit.
If serum EPO levels are elevated, one attempts to distinguish whether the
elevation is a physiologic response to hypoxia or is related to autonomous
production.